Some people are more willing to make immediate, risky, or costly reward-focused choices than others, which has been hypothesized to be associated with individual differences in dopamine (DA) function. In two studies using PET imaging, one empirical (Study 1: N=144 males and females) and one meta-analytic (Study 2: N=307), we sought to characterize associations between individual differences in DA and time, probability, and physical effort discounting in human adults. Study 1 demonstrated that individual differences in DA D2-like receptors were not significantly associated with time, probability, or physical effort discounting of monetary rewards in healthy humans. Meta-analytic results for temporal discounting corroborated our empirical finding for minimal effect of DA measures on discounting in healthy individuals, but suggested that associations between individual differences in DA and reward discounting depend on clinical features. Addictions were characterized by negative correlations between DA and discounting but other clinical conditions like Parkinson's Disease, obesity, and ADHD were characterized by positive correlations between DA and discounting. Together the results suggest that trait differences in discounting in healthy adults do not appear to be strongly associated with individual differences in D2-like receptors. The difference in meta-analytic correlation effects between healthy controls and individuals with psychopathology suggests that individual difference findings related to DA and reward discounting in clinical samples may not be reliably generalized to healthy controls, and vice-versa.
Introduction
Discounting is a natural phenomenon that describes the tendency to devalue rewards that are relatively delayed, uncertain, or require more effort than sooner, more certain, or less effortful ones. Individual differences in discounting in humans have been hypothesized to be strongly related to individual differences in dopamine (DA) function. Studies of human and nonhuman animals have reported that pharmacological effects on DA D2-like receptors alter discounting (Salamone et al., 1996; St Onge et al., 2010; Koffarnus et al., 2011; Weber et al., 2016) . Specifically, D2-like receptors are believed to regulate decisions to inhibit impulsive actions (Frank, 2005; Ghahremani et al., 2012; Robertson et al., 2015) like choosing smallersooner/more-likely/less-effortful rewards. However, studies of the transient manipulation of the DA system do not clarify whether more persistent individual differences in decision making are also primarily mediated by differences in DA D2-like receptor expression.
Multiple studies have reported links between discounting behavior and forms of psychopathology that are associated with alteration in striatal DA function including: drug addiction (MacKillop et al., 2011; Amlung et al., 2017) , obesity (Amlung et al., 2016) , schizophrenia and bipolar disorder (Ahn et al., 2011) , attention-deficit/hyperactivity disorder (ADHD) (Amlung et al., 2016) , and Parkinson's disease (PD) (Kaasinen and Vahlberg, 2017) .
While these studies suggest a common involvement of DA in discounting in disease, it leaves open questions about specific features and clinical range of influence between DA and discounting behavior.
Only a few studies have directly assessed associations between trait-like individual differences in DA function and discounting behavior. Several recent studies using positron emission tomography (PET) suggest that reduced availability of DA receptors contributes to greater discounting (See Table 1 for a summary of dopamine PET studies of reward discounting). However, many existing studies are limited by small sample sizes (Button et al., 2013) , a focus on only temporal discounting (Crunelle et al., 2014; Ballard et al., 2015; Cho et al., 2015; Joutsa et al., 2015; Oberlin et al., 2015; Smith et al., 2016) or a mixture of decision features which may or may not be dissociable (Treadway et al., 2012) , use of radiotracers with limited visibility outside the striatum (e.g., [11C]raclopride), or assessment of individuals with psychopathology (that vary in DA and other neuromodulatory functions) (Crunelle et al., 2014; Ballard et al., 2015; Eisenstein et al., 2015; Joutsa et al., 2015; Oberlin et al., 2015) . Although prior PET studies have largely focused on the striatum, DA neurons in the midbrain also project to the amygdala, hippocampus, thalamus, anterior cingulate, insula, and frontal and parietal lobes (Bjorklund et al., 1978; Berger et al., 1991) . Accordingly, there may be subtle differences in how DA function uniquely accounts for different types of discounting across the brain in individuals who vary in DA status.
It remains unclear whether there exists a reliable association between individual differences in DA and discounting in healthy humans. Here, in two studies, one empirical and one meta-analytic, we sought to characterize the relationship between individual differences in DA and decision making in healthy human adults. In study 1, we analyzed data from three samples of healthy adults (young adults, N=25, and adult life-span, N=84, N=35). We estimated time, probability, and effort discounting of monetary rewards using multiple tasks that attempted to dissociate discounting of these three decision features and estimated DA D2-like receptor availability using PET imaging with two different radiotracers, [18F]fallypride and [11C]FLB 457, with complementary coverage of striatal and extra-striatal brain regions (Cropley et al., 2006) . In study 2, we performed a quantitative meta-analysis to examine the consistency of or variation in individual differences across PET imaging studies of DA and discounting in healthy human adults and clinical groups. Table 1 . Summary of past reward discounting studies using PET imaging. Note that effect sizes are shown as originally reported but Fisher r-to-Z values have been sign-flipped when necessary to facilitate comparison of discount measures across studies. Non-treatment seeking alcoholism, SD = social drinker, OB = Obesity; (+: increased discounting, -: decreased discounting, ∩: inverted-U effect from mPFC rTMS, n.s.: non-significant effect); vs = ventral striatum, mPFC = medial prefrontal cortex; * = DA release, ** = median-split of FMT statistically significant, *** = statistic from reported peak voxelwise result
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Materials and Methods
Study 1
Participants and procedures. The data analyzed here were collected from three different samples at two different universities. They will be described as samples 1-3. Sample 1 included twenty-five healthy young adults (ages 18-24, M=20.9, SD=1.83, 13 females) recruited from the (First, 1997) , any history of head trauma, any significant medical condition, or any condition that would interfere with MRI (e.g. inability to fit in the scanner, claustrophobia, cochlear implant, metal fragments in eyes, cardiac pacemaker, neural stimulator, pregnancy, and metallic body inclusions or other contraindicated metal implanted in the body). Participants with major medical disorders including diabetes and/or abnormalities on a comprehensive metabolic panel, complete blood count, or EKG were excluded. Participants were also excluded if they reported a history of substance abuse, current tobacco use, alcohol consumption greater than 8 ounces of whiskey or equivalent per week, use of psychostimulants (excluding caffeine) more than twice at any time in their life or at all in the past 6 months, or any psychotropic medication in the last 6 months other than occasional use of benzodiazepines for sleep. Any illicit drug use in the last 2 months was grounds for exclusion, even in participants who did not otherwise meet criteria for substance abuse. Urine drug tests were administered, and subjects testing positive for the presence of amphetamines, cocaine, marijuana, PCP, opiates, benzodiazepines, or barbiturates were excluded. Pre-menopausal females had negative pregnancy tests at intake and on the day of the scan. There were minor differences in exclusion thresholds between samples 1/2 and sample 3 based on the location and full study protocol (e.g., a subset of subjects in sample 3 also received an oral dose of d-amphetamine). For full screening details see .
PET imaging: [18F]fallypride data acquisition and preprocessing (Samples 1 and 2).
[18F]fallypride, (S)-N- (Carson et al., 2004) . Event-by-event, motion correction (Jin et al., 2013) was applied using a Polaris Vicra optical tracking system (NDI Systems, Waterloo, Canada) that detects motion using reflectors mounted on a cap worn by the subject throughout the duration of the scan. Prior to the PET scan, T1-weighted magnetic resonance (MR) images (MPRAGE protocol; TR = 2.4 s, TE = 1.9 ms, FOV = 256 × 256 mm, voxel size = 1 × 1 × 1 mm) were acquired on a 3T Trio whole-body scanner (Siemens Medical Systems, Erlangen, Germany). After decay correction and attenuation correction, PET scan frames were corrected for motion using SPM8 (Friston et al., 1994) with the 20th dynamic image frame of the first series serving as the reference image.
The realigned PET frames were then merged and re-associated with their acquisition timing info in PMOD's PVIEW module to create a single 4D file for use in PMOD's PNEURO tool for further analysis.
Binding Potential Calculation. We estimated D2 receptor availability as binding potential (BPND) using the simplified reference tissue model (SRTM) with the cerebellum as the reference region) (Lammertsma and Hume, 1996) via two approaches: voxelwise and ROI-based (by fitting time activity curves). PMOD's PXMOD tool was used to estimate BPND voxel-wise using a published basis function fitting approach (Gunn et al., 1997) . See Figure 1 for average voxelwise BPND images from all three samples. The set of regions of interest did not completely overlap across samples due to differences in regional coverage of the radiotracers (samples 1, 2, 3: midbrain, thalamus, amygdala, hippocampus, anterior cingulate cortex (ACC), and insula; samples 1 and 2: ventral striatum, caudate, putamen). The midbrain was drawn in MNI standard space using previously described guidelines (Mawlawi et al., 2001; Dang et al., 2012b; Dang et al., 2012a) shown that many brain regions may be susceptible to partial volume effects in estimating BPND especially in older adults as a result of age differences in gray matter volume .
PVC increased estimated binding potential across adults of all ages while also increasing individual differences not related to age . Therefore, we used PVC values in all analyses presented here with the exception of the midbrain for which we used uncorrected BPND for analysis, because it was not available in the Hammers Atlas in PNEURO. We shared both corrected and uncorrected values for all ROIs if others want to do additional analysis. These data can be accessed at https://osf.io/htq56/.
We extracted mean D2-like BPND from the midbrain (mean ± SD: Reward discounting tasks. All samples completed a temporal discounting task (N=144), samples 2 and 3 also completed a probability discounting task (N=119), and sample 2 also completed a physical effort discounting task (N=84). All tasks were incentive-compatible (played for real cash earnings) and performed during fMRI scanning (samples 1 and 2) or on a computer in a behavioral lab (sample 3) on a separate visit from the PET imaging session as part of larger multimodal neuroimaging studies.
Temporal discounting task. All three samples completed a temporal discounting task adapted from a previously used paradigm (McClure et al., 2004) . On each trial, participants chose between an early monetary reward and a late reward. In sample 1, the delay of the early reward was set to today, 2 weeks, or 1 month, while the delay of the late reward was set to 2 weeks, 1 month, or 6 weeks after the early reward. In samples 2 and 3, the delay of the early reward was set to today, 2, or 4 weeks, while the delay of the late reward was set to 2, 4, or 6 weeks after the early reward. In all samples, the early reward magnitude ranged between 1% and 50% less than the late reward. Participants in sample 1 played 84 (42 trials in two runs) trials of the temporal discounting task and participants in samples 2 and 3 played 82 trials (41 trials in two runs). One participant in sample 3 had missing data for this task, producing a total sample size of 143 participants with temporal discounting data across all samples.
Probabilistic discounting task. Samples 2 and 3 completed a probabilistic decision making task similar to commonly used two-alternative forced choice mixed gamble tasks (Levy and Glimcher, 2012) . On each trial, participants chose between a smaller monetary reward with a higher probability and a larger reward with a lower probability. The probability of the higher probability reward was set to 50%, 75%, or 100%, while the probability of the lower probability reward was set to 25% or 50% lower. The higher probability reward magnitude ranged between 1% and 50% lower compared to the lower probability reward. Participants in samples 2 and 3 played 82 trials of the probability discounting task. Data for this task was available for all participants, producing a total sample size of 119 participants with probability discounting data.
Effort discounting task. The Effort Expenditure for Rewards Task (EEfRT) was adapted from an existing paradigm that used finger pressing as the physical effort required for earning a reward (Treadway et al., 2009 ). On each trial, participants chose between a smaller monetary reward available for a lower amount of physical effort (pinky finger button presses) and a larger reward available for a higher amount of effort. The effort required for the smaller reward was set as 35%, 55%, or 75% (of each participant's maximum press rate), while the effort required for the larger reward was set as 20% or 40% higher than the smaller reward (i.e., 55%, 75%, or 95%). The number of button presses required for each level of effort was individually determined based on an initial calibration procedure in which participants pressed a button with their pinky finger as many times and as rapidly as possible in a few short intervals. The smaller magnitude reward ranged between 1% and 50% lower than the larger reward. On half of the trials, after making a choice participants were shown a 1-second "Ready" screen and then completed the button-pressing task. Participants in sample 2 played 82 trials of the effort discounting task. No participant had missing data for this task, producing a total sample size of 84 participants with effort discounting data.
Computational modeling of reward discounting. In addition to a simple calculation of the proportion of smaller magnitude (less delayed/higher probability/lower effort) reward choices,
we used a computational model to estimate behavioral preferences. For each participant and each task, discounting was modeled with a hyperbolic discounted value function, = 1+ , where R represents the monetary reward magnitude, k represents the discount rate, and C represents either: (1) proportion of maximum finger press rate for effort, (2) odds against winning (1p(win))/p(win)) for probability, or (3) delay in days for time. Data were fit with a softmax as the slope of the decision function. Since k values are not normally-distributed, we used natural logtransformed values Ln(k+1). Past work from our lab has shown k values and simple proportion of smaller reward choices are highly correlated (Seaman et al., 2018) . We report both scores for transparency.
Experimental Design and Statistical Analysis.
To determine whether D2-like receptor availability in the midbrain, striatum, and extrastriatal regions were associated with discounting, we combined one sample of healthy young adults with two cross-sectional healthy adult life-span samples. We ran linear regressions between BPND and the proportion of sooner/higher probability/lower effort choices as well as k-values. Regressions included control variables for age, sex, study, and radiotracer (where appropriate). We corrected for multiple comparisons within each cost domain (time, probability, effort) for each region available for each combination of samples since not all samples were tested on all tasks or had BPND for all regions. We applied
Bonferroni-correction to p-values as follows: midbrain =.05; striatal ROIs = .05/3 =.016;
extrastriatal ROIs = .05/5 =.010. Previous work has documented associations between discounting and household income and education (de Wit et al., 2007; Reimers et al., 2009 ).
Since we did not identify such associations between education or income with discounting in any task, we did not include these measures as covariates in regressions.
Exploratory voxelwise statistical testing of D2-like receptor availability was separately carried out for each discounting task in each sample in MNI standard space. Since [11C] FLB 457 was acquired on a high resolution scanner which produced maps with lower local spatial correlation, we spatially smoothed these BPND maps with a 5mm FWHM Gaussian kernel to increase spatial SNR (Christopher et al., 2014; Plaven-Sigray et al., 2017) . Linear regressions examining the effect of proportion of sooner/higher probability/lower effort choices on voxelwise BPND with age and sex as covariates were carried out using FSL Randomise (Version 2.9) within each sample. Threshold-free cluster enhancement (Smith and Nichols, 2009 ) was used to detect regions with significant correlations across the whole brain with non-parametric permutation tests (5,000 permutations). Statistical maps were thresholded at p < 0.05.
Study 2
To identify research studies of interest, a PubMed search for the following terms (((Dopamine) AND positron emission tomography) AND humans) AND (discounting OR impulsive choice) yielded 10 studies. Five of these studies included original analysis of the relationship between preferences in a discounting task and a PET measure of DA function and were included. An additional exhaustive search via Google Scholar identified 3 additional relevant and includable studies. Notably, six of the studies in the meta-analysis used tracers that bind to D2-like receptors for baseline receptor availability or DA release measures (Treadway et al., 2012; Ballard et al., 2015; Cho et al., 2015; Eisenstein et al., 2015; Joutsa et al., 2015; Oberlin et al., 2015) , two used tracers that measure presynaptic DA uptake (Joutsa et al., 2015; Smith et al., 2016) , and one used a tracer that binds to dopamine transporters (DAT) (Crunelle et al., 2014) . The study measuring DAT reported methylphenidate (MPH) occupancy after drug administration. To obtain the DAT BPND measure, we sign-flipped the correlation since DAT BPND is inversely related to MPH occupancy. In addition to the present study (Study 1) that examined time, probability, and effort, one other study examined both time and probability discounting (Eisenstein et al., 2015) , another study examined effort-based discounting (Treadway et al., 2012) , and the remaining studies examined only time discounting. One of these studies used single photon emission computerized tomography (SPECT) rather than PET and was included. If correlation coefficients were not reported, t-statistics and degrees of freedom were used to generate correlation coefficients. Because correlations are bound and can be skewed, they were Fisher r-to-Z transformed before meta-analysis. In the case of one study (Treadway et al., 2012) , correlations between caudate D2-like receptor BPND and preferences for effort were originally reported as three within-task correlations (by probability condition). To approximate the full task correlation, we used the Fisher r-to-Z transformation for the three correlations and then averaged these values. Depending on the decision preference index reported (Ln(k), proportion smaller, area-under-the-curve, etc.), we sign-flipped Z-scores so that more positive values reflected greater discounting (e.g., less willing to choose a larger, delayed/uncertain/effortful reward). One study did not assess or report linear correlations (Cho et al., 2015) . A summary of these studies is presented in Table 1 .
Since our group previously reported little to no correlation between time, probability, and effort discounting in sample 2 (Seaman et al., 2016) , we limited the meta-analysis to time discounting measures only. Therefore, the meta-analysis included 7 studies with 14 correlation effects (including the effect of time discounting from the present study). The goal of the metaanalysis was to identify generalizable patterns that address the broader question of whether discounting is related to general striatal dopamine function. Since prior reports indicated that D2 receptor availability, DA release, DA synthesis capacity, and DAT availability are correlated within individuals (Volkow et al., 1998; Volkow et al., 2002; Yang et al., 2004; Sun et al., 2012; Berry et al., 2018) , we included all studies that reported a correlation with a striatal region. It should be noted that indices of any one of these radiotracer targets alone may not be reflective of general dopamine function, but contribute to and interact within complex spatiotemporal circuits that impact dopaminergic synapses. If a study reported multiple striatal regions, we used the reported t-statistics and p-values to select only the region with the largest effect size. Since this resulted in inconsistent ROIs (with 6 effects in the whole striatum, 6 in the ventral striatum, 2 in the caudate, and 2 in the putamen), we compared the correlation between time discounting in the present study with D2-like receptor availability in the whole striatum. BPND for the whole striatum was calculated as a volume-weighted average of the caudate, putamen, and ventral striatum PVC BPND values. Included effects from the present study controlled for age, sex, and study sample. Replacing the whole striatum value with the largest substriatal effect size value in our study (ventral striatum) did not change the pattern of results.
Meta-analytic effects were derived using the metafor R package (Viechtbauer, 2010) in JASP (Version 0.8.5.1) using random effects with restricted maximum-likelihood (JASP, 2018) to help account for between-study variance. An initial meta-analysis across all studies evaluated whether the common correlation (intercept) was significantly greater than zero, p < .05. Since the study samples included groups with psychopathology and radiotracers that bind to different dopaminergic targets, we ran additional meta-analytic models to evaluate whether effect sizes depended on the interaction of these terms. We dummy-coded study populations as either belonging to a group that is characterized by addiction, healthy controls, or any other psychopathology or disease. We coded the following as addiction: pathological gambling, methamphetamine users, and non-treatment-seeking alcoholism. Other psychopathology samples included obesity, PD, and treatment-naïve ADHD samples. Radiotracer targets were either D2like receptors (D2R) including baseline and release measures, DA synthesis capacity (SC), or dopamine transporters (DAT). We used the Q-statistic to test the null hypothesis that the common true correlation is zero and I 2 values to assess significance due to variance explained by heterogeneity of the effects (Borenstein, 2009) . Model fit quality statistics are reported for the intercept model and the interaction model, along with each of the interaction main effect terms alone. We evaluated publication bias and study precision asymmetry with visual inspection of a funnel plot and Egger's test (p < .05).
Results
Study 1
Discounting across studies. Average behavioral measures of time and probability discounting did not differ between samples (time: F(2,140) = 1.63, p = .200; probability:
F(1,117) = .009, p = .925), facilitating our ability to combine samples for analysis. Simple choice proportions (e.g., smaller-sooner / total number of choices) were highly correlated with computationally-estimated discount rates Ln(k+1) for time (r141 = .829, p < .001), probability (r117 = .798, p < .001), and effort (r82 = .830, p < .001). Note that any associations or lack of associations with behavioral measures of effort discounting should be viewed with caution given that most participants selected larger/high-effort choices.
Age effects on Discounting and D2-like receptor availability. Samples 2 and 3 included adults of all ages. Age was not reliably associated with reward discounting of time (r141 = .049, p = .563), probability (r117 = -.007, p = .947), or effort (r82 = .116, p = .293 Correlations between age and discounting within sample 2 were previously reported in (Seaman et al., 2018) . Correlations between age and BPND for samples 2 and 3 were previously reported in and .
Discounting and D2-like receptor availability. We did not identify associations between D2-like BPND in the midbrain and discounting across samples 1, 2, and 3 or the striatum and discounting across samples 1 and 2 (Table 3) . We identified a modest positive correlation between probability discounting and D2-like receptor availability in the hippocampus (Ln(k+1): β = .197, SE = .110, t114 = 2.06, p = .042). However, the correlation did not survive correction for multiple comparisons. No associations were identified between discounting and any of the other ROIs (Table 3 and Figure 2 ). Voxelwise analysis of binding potential maps also did not reveal any significant correlations with discounting. Unthresholded statistical maps can be viewed/downloaded from NeuroVault at: https://neurovault.org/collections/ZPFBVXPK/
Figure 2. Correlations between reward discounting and D2-like receptor availability.
Correlation plots depict associations between D2-like receptor availability (PVC) and proportion of smaller sooner / higher probability / less effortful choices. Individual subject data points are depicted for time in turquois, probability in pink, and effort in green. Solid lines represent regression slopes for [18F]fallypride and dotted lines represent regression slopes for [11C]FLB 457. Table 3 . Region of interest analyses for D2-like receptor availability (PVC) showing standardized regression coefficients (after adjustment for control variables) and 95% confidence intervals. S1 = sample 1, S2 = sample 2, S3 = sample 3.
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Study 2
Meta-analysis: DA PET studies of reward discounting. An initial meta-analysis across all studies of temporal discounting did not identify a significant common correlation between discounting and kinetic measure of DA function (Omnibus test of model coefficients, Cochran's Q = 1.03, p = .310, I 2 = 84.7%; βintercept = -.167, SE = .164, Z = -1.02, AIC = 28.6).
Alternatively, a model that included the interaction between psychopathology group and radiotracer target provided a better fit than the common correlation model (without interaction terms) and accounted for the heterogeneity of effects (Omnibus test of model coefficients, Cochran's Q = 35.2, p < .001, I 2 = 37.15%, AIC = 19.8). Inspection of the coefficients suggested that psychopathology alone had a greater impact on the model than radiotracer target: βHealthy,D2receptor/intercept = -.088, SE = .124, Z = -.708, p = .479, βDA synthesis capacity = -.479, SE = .357, Z = -1.34, p = .180, βDAT = -.034, SE = .410, Z = -.084, p = .933, βAddiction = -.676, SE = .215, Z = -3.14, p = .002, βOther Psychopathology = .720, SE = .317, Z = 2.27, p = .023, βOther Psychopathology, DA synthesis capacity = .605, SE = .566, Z = 1.07, p = .285.
A follow-up model with the radiotracer target interaction term alone provided a worse fit (Omnibus test of model coefficients, Cochran's Q = 2.59, p = .273, I 2 = 83.9%, AIC = 28.4). Figure 3 . Plotted values depict Pearson correlation coefficients for display purposes only. Visual inspection of asymmetry in a funnel plot of effects from the psychopathology model ( Figure 2) and Egger's test (Z = -2.24, p = .025) indicated some potential publication bias associated with differences between studies reporting effects in specific psychopathology groups. Egger's test did not indicate the presence of publication bias in the common correlation model (Z = -1.80, p = .072) or full interaction model (Z = -1.56, p = .119).
The nature of the psychopathology group effect was that healthy individuals showed a non-significant, small, negative correlation between DA and discounting, the addiction groups showed a significant and stronger negative association, and the other psychopathology groups showed a stronger positive association relative to healthy controls. To facilitate comparison of group effects with past and future studies, we converted estimated coefficient Z-values back to Pearson correlation coefficients. The correlation for the healthy group was r = -.137, 95% CI [-.339, .076], the correlation for the addiction group was r = -.638, 95% CI [-.796, -.399] , and the correlation for the other psychopathology group was r = .575, 95% CI [.319, .753 ]. Including additional data from studies using effort and probability discounting measures did not change the pattern of results (see additional data and figures shared on OSF at https://osf.io/htq56/).
Figure 3. Meta-analytic comparison of associations between individual differences in dopamine and reward discounting.
The forest plot on the left shows variation in effect sizes according to clinical status (healthy, addiction, and other psychopathology). Values depict correlation coefficients, r, for display purposes; positive values indicate a positive correlation between DA function and greater discounting (e.g., more immediate choices). Black diamonds represent individual study effects (diamond size depicts the weight in the meta-analysis and the horizontal lines represent 95% confidence intervals of the individual effects, noted on the right). Gray diamonds represent 95% confidence intervals of the factor coefficients from the interaction term (clinical status). The funnel plot is displayed in the lower right for the model. Plotted points represent individual effects. Points represent the residuals of the psychopathology groups and their associated study precision (standard error). When the effect residuals lie within the unshaded area, it implies that heterogeneity in the main effect is successfully accounted for by the interaction model. Points within the unshaded region correspond to p-values greater than .10 while p-values in the light gray and dark gray regions correspond to p-values between .10 and .05 and between .05 and .01, respectfully.
Discussion
Here, we examined whether time, probability, and effort discounting of monetary rewards were related to individual differences in DA function in humans. We found that preferences for shorter time delays, higher probability, and lower physical effort were generally uncorrelated with DA D2-like receptor availability across brain regions in healthy adults. We identified a weak positive correlation between time discounting and D2-like receptors in the hippocampus, however, this effect did not remain significant after correction for multiple comparisons.
A meta-analysis comparing correlations between discounting and striatal dopamine function failed to detect a correlation greater than zero across all studies. Consistent with Study 1, D2 binding and discounting in healthy groups were unrelated. However, there was a heterogeneity of findings dependent on psychopathology, with addiction showing a strong negative relationship to D2 binding. Taken together, these findings suggest that individual differences in D2-like receptors are not reliably associated with discounting in healthy adults.
Despite numerous past findings suggesting a role for DA in reward discounting behavior, the present findings raise questions about the specific role of D2-like receptors in discounting.
The difference in correlations between healthy adults and clinical groups in the metaanalysis suggests that individual differences may depend on alterations in striatal DA function. In addictions, striatal D2-like receptor expression is diminished. This lowered striatal D2-like receptor expression may not be compensated by other features of the DA system such as synthesis capacity, release, re-uptake, or metabolism, which also become dysregulated in addictions (Volkow et al., 2009) . As a result, it is possible that effects on temporal discounting emerge when the system is dysregulated. Dysregulation in different features of the DA system may contribute to non-linear individual differences. The inverted-U hypothesis, for example, has been invoked often to characterize individual difference associations between DA and cognition, especially working memory (Vijayraghavan et al., 2007; Cools and D'Esposito, 2011) . In this case, changes in postsynaptic D2-like receptors may shift the relative balance in extracellular DA binding with D1-like receptors. A number of studies have proposed similar inverted-U associations between striatal DA function and trait-level sensation-seeking (Gjedde et al., 2010) or fMRI reward signals (Dreher et al., 2008) , and cortical DA and delay discounting (Smith and Boettiger, 2012; Elton et al., 2017) . The present meta-analytic results revealed little to no association in the healthy range and correlations in the positive and negative directions with psychopathology associated with disrupted DA function-akin to an inverted-U. An inverted-U relationship driven by dysregulation of striatal DA may account for the differential associations between discounting and D2-like receptors between healthy and clinical groups. Future studies of reward discounting in individuals with a broad range of types of disruptions in DA are needed to properly test this hypothesis.
Importantly, the measures of baseline D2-like receptor availability were static and cannot describe temporal changes in dopamine signaling related to reward cues. Potentially, individual differences only emerge as a result of temporal dynamics of DA midbrain spiking or DA release (which may also be affected by psychopathology). For example, phasic changes in rodents' striatal dopamine release vary with discounting behavior (Moschak and Carelli, 2017) and subjective value (Schelp et al., 2017) . It remains unknown whether phasic changes might better explain individual differences in human reward discounting. In human studies, for example, fMRI activation linked to the decision process (like subjective valuation) may better capture individual difference associations with baseline DA function. This does not imply that baseline DA function does not index individual differences in behavior generally, but it does call into question whether the range of discounting behavior in healthy individuals can be explained by baseline DA function alone.
The striking difference in meta-analytic correlation effects between healthy controls and individuals with psychopathology suggests that individual difference findings in clinical samples cannot be reliably generalized to healthy controls, and vice-versa. Disruption of brain function as a result of addiction, ADHD, obesity, and Parkinson's disease is not limited to a striatal DA abnormality and is much more widespread across systems. Alterations in the DA system may interact with changes to broader neural systems. For example, a systems model of addiction suggests multiple cognitive and motivational corticostriatal circuits interact and compensate for disruptions in glutamatergic and GABAergic prefrontal signaling (Volkow et al., 2011) .
Disruptions to these circuits may affect the relationship between DA and discounting behavior in addiction (MacKillop et al., 2011) . In the context of reward processing, DA release in the striatum impacts cholinergic (Wang et al., 2006) , glutamatergic, and GABAergic signaling (Alexander and Crutcher, 1990; Karreman and Moghaddam, 1996) . Changes in these other systems may moderate effects of D2 receptors on discounting, although future studies with direct measures of these system interactions are needed to evaluate this possibility.
Two of the samples in our empirical analysis included age ranges wider than most PET studies of DA. Although age was negatively correlated with D2-like receptor availability, we did not observe age-related associations with discounting in any of the tasks. Although some prior studies described age differences in discounting (Green et al., 1999; Simon et al., 2010) , the lack of an association in the present study is consistent with a recent study of over 23,000 participants aged 18-101 which also did not identify a correlation between age and time discounting (Sanchez-Roige et al., 2018) . Well-documented age-related D2 receptor loss with no changes in discounting behavior across the literature is complementary evidence that individual differences in discounting are not likely to be D2-mediated in healthy adults. Further, controlling for age did not substantially change any of the results presented here, suggesting that the broad age range of our samples did not account for the lack of effects. Rather, the advantage of studying an adulthood sample is that our results better generalize to the human adult population.
There are several weaknesses of the present studies. Since the finger-pressing requirement for the effort task was not very difficult for participants in Study 1, additional studies that elicit broader individual differences in preferences are needed to better evaluate associations between D2 receptors and effort discounting. Although we included data from multiple studies using tracers with complementary coverage, our empirical study was limited to D2-like receptors. Future studies may benefit from comparing in the same individuals, for example, D2-like receptors and DAT, the latter of which have been more consistently associated with altering discounting behavior (Wade et al., 2000; van Gaalen et al., 2006; Koffarnus et al., 2011) . Despite the inclusion of studies with effects for DA synthesis capacity, DA release, and DAT expression, radiotracer target did not impact the overall effects and analysis restricted to D2 receptors did not impact results. Nonetheless, it is difficult to generalize about the directionality of effects in relation to temporal discounting with these different radiotracer targets since there were only one DAT, two DA synthesis, and two DA release effects. Although the meta-analysis included studies with subject samples varying broadly in clinical status, there was often only one effect per diagnostic group. Importantly, effects from the other psychopathology group that included ADHD, obesity, and PD should be interpreted with caution. Although these groups are similar in that they are impacted by alterations in DA function, there are differences in how DA is dysregulated in each of them (presynaptic synthesis capacity, DA reuptake, postsynaptic receptor expression, etc.) (Madras et al., 2005; Benton and Young, 2016; Kaasinen and Vahlberg, 2017) . Grouping of addictions might present issues (though less so than grouping of non-addiction) with respect to illness duration since alterations to DA can exhibit different immediate and long-term changes with drug use (Volkow et al., 2009) . Although our metaanalytic results were restricted to temporal discounting, they were not impacted by the inclusion of correlations for probability and effort discounting tasks. Unfortunately, there are too few of these different task associations to properly evaluate them in relation to D2-like receptor availability. Further, the absence of a strong relationship between time, probability, and effort discounting in our empirical analysis complicates our ability to generalize preferences in these tasks. It is possible that the meta-analytic effects observed for time discounting may be different if a greater number of effects for probability and effort were observed. For example, work by behavioral economists have identified cases in which gamblers discount over time but exhibit risk insensitive preferences (Holt et al., 2003) , suggesting that probability and time discounting may be different in addiction. Thus, to better characterize specific diagnostic groups affected by alterations in DA function, more studies are needed to evaluate associations with various forms of discounting.
The present findings indicated that individual differences in D2-like receptor availability are not correlated with trait-level individual differences in reward discounting. Our combination of a relatively large empirical study with a meta-analysis adds confidence to the findings and avoids the common weakness of human PET studies, especially individual difference studies, that typically lack statistical power. Future studies specifying the relationship between baseline DA function, temporal dynamics of DA release, and discounting will likely provide additional insight into how dopaminergic control of signaling influences decision preferences in healthy individuals.
